Columbia Care Inc
F:3LP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Columbia Care Inc
Change in Working Capital
Columbia Care Inc
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Columbia Care Inc
F:3LP
|
Change in Working Capital
-$50.5m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Change in Working Capital
-$12.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Change in Working Capital
-$455m
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
|
Pfizer Inc
NYSE:PFE
|
Change in Working Capital
-$5.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-81%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Change in Working Capital
-$7B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-39%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Change in Working Capital
-$8.1B
|
CAGR 3-Years
-2 063%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
-22%
|
|
Columbia Care Inc
Glance View
Columbia Care, Inc. engages in the cultivation, manufacture and provision of medical cannabis products and services. The company is headquartered in New York City, New York. The company went IPO on 2019-04-29. The firm is engaged cultivating, manufacturing and providing medical and adult use cannabis products and related services with licenses in over 18 the United States jurisdictions and the European Union (EU). The firm operates facilities including dispensaries and cultivation and manufacturing facilities. The firm operates as the original providers of medical cannabis in the United States and continues to deliver a patient-centered medicinal cannabis operation. The firm offers products spanning flower, edibles, oils, and tablets, and manufactures brands including Seed & Strain, Amber and Platinum Label Cannabidiol (CBD) products. The company develops products which comprised of a variety of medical and adult-use form factors, including but not limited to formulations, precision manufactured dosing and cannabis flower and flower-derived products.
See Also
What is Columbia Care Inc's Change in Working Capital?
Change in Working Capital
-50.5m
USD
Based on the financial report for Dec 31, 2022, Columbia Care Inc's Change in Working Capital amounts to -50.5m USD.
What is Columbia Care Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
-66%
The average annual Change in Working Capital growth rates for Columbia Care Inc have been -66% over the past three years .
